DE60218375D1 - Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen - Google Patents
Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer ErkrankungenInfo
- Publication number
- DE60218375D1 DE60218375D1 DE60218375T DE60218375T DE60218375D1 DE 60218375 D1 DE60218375 D1 DE 60218375D1 DE 60218375 T DE60218375 T DE 60218375T DE 60218375 T DE60218375 T DE 60218375T DE 60218375 D1 DE60218375 D1 DE 60218375D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- pharmaceutical composition
- gynecological diseases
- gynecological
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001100426 | 2001-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60218375D1 true DE60218375D1 (de) | 2007-04-12 |
Family
ID=18953869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60218375T Expired - Fee Related DE60218375D1 (de) | 2001-03-30 | 2002-03-27 | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen |
Country Status (3)
Country | Link |
---|---|
US (1) | US7041310B2 (de) |
EP (1) | EP1249247B1 (de) |
DE (1) | DE60218375D1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7799766B2 (en) * | 1998-04-08 | 2010-09-21 | Theta Biomedical Consulting & Development Co., Inc. | Composition for treating hormonally-dependent cancers |
DE10147186A1 (de) * | 2001-09-25 | 2003-04-24 | Beiersdorf Ag | Wirkstoffkombinationen aus Polyhexamethylenbiguanid-Hydrochlorid und Distearyldimethylammoniumchlorid und Zubereitungen, solche Wirkstoffkombinationen enthaltend |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
AU2004203700B2 (en) * | 2003-01-02 | 2007-06-21 | Femmepharma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
JP4459543B2 (ja) | 2003-03-17 | 2010-04-28 | 株式会社メドジェル | 徐放性ハイドロゲル製剤 |
JP2004323454A (ja) * | 2003-04-25 | 2004-11-18 | Chisso Corp | 薬剤 |
US7276486B2 (en) * | 2004-03-15 | 2007-10-02 | Kimberly-Clark Worldwide, Inc. | Compositions for vaginal treatment |
US20050220912A1 (en) * | 2004-03-30 | 2005-10-06 | Theoharides Theoharis C | Anti-inflammatory composition for treating pelvic endometriosis |
US20070154546A1 (en) * | 2005-12-30 | 2007-07-05 | Zhang Jack Y | Sustained release pharmaceutical compositions |
WO2008083158A2 (en) * | 2006-12-26 | 2008-07-10 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
WO2008144143A1 (en) * | 2007-05-14 | 2008-11-27 | Drugtech Corporation | Endometriosis treatment |
US8282612B1 (en) | 2008-03-07 | 2012-10-09 | Denise H. Miller | Methods and devices for intrauterine absorption |
US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
US9078786B1 (en) | 2012-10-19 | 2015-07-14 | Denise H. Miller | Methods and devices for collecting body fluids |
CZ2013914A3 (cs) | 2013-11-21 | 2015-02-25 | Contipro Biotech S.R.O. | Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití |
CN108853569B (zh) * | 2018-06-27 | 2021-06-11 | 湖南玉津医疗科技有限公司 | 一种共价交联透明质酸气凝胶及其水凝胶以及制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
JP2590358B2 (ja) * | 1988-03-01 | 1997-03-12 | 正雄 五十嵐 | 子宮内膜症治療用の子宮内又は膣内投与製剤 |
IT1247472B (it) * | 1991-05-31 | 1994-12-17 | Fidia Spa | Processo per la preparazione di microsfere contenenti componenti biologicamente attivi. |
JP2855307B2 (ja) * | 1992-02-05 | 1999-02-10 | 生化学工業株式会社 | 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法 |
IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
JP3390477B2 (ja) * | 1993-01-25 | 2003-03-24 | 生化学工業株式会社 | 薬剤組成物及びその製造法 |
JP3563440B2 (ja) | 1994-05-16 | 2004-09-08 | 生化学工業株式会社 | アシル化ヒアルロン酸の製造法 |
JP3556975B2 (ja) | 1994-08-11 | 2004-08-25 | 株式会社資生堂 | アセチル化ヒアルロン酸の製造方法及び精製方法 |
WO1996005233A1 (fr) * | 1994-08-11 | 1996-02-22 | Shiseido Co., Ltd. | Acide hyaluronique acetyle a faible poids moleculaire, emollient, et procedes d'obtention et de purification de cet acide |
CA2237192C (en) | 1995-11-15 | 2006-06-20 | Seikagaku Corporation | Photocured crosslinked-hyaluronic acid gel and method of preparation thereof |
IT1317358B1 (it) * | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
US6673919B2 (en) * | 2001-03-30 | 2004-01-06 | Chisso Cororation | Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof |
-
2002
- 2002-03-27 EP EP02007213A patent/EP1249247B1/de not_active Expired - Lifetime
- 2002-03-27 DE DE60218375T patent/DE60218375D1/de not_active Expired - Fee Related
- 2002-03-28 US US10/108,298 patent/US7041310B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1249247A2 (de) | 2002-10-16 |
US20020150605A1 (en) | 2002-10-17 |
US7041310B2 (en) | 2006-05-09 |
EP1249247B1 (de) | 2007-02-28 |
EP1249247A3 (de) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60232251D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
FIU20060389U0 (fi) | Luusairauksien hoito | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
NO20033594D0 (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
ATE551100T1 (de) | Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen | |
ATE440866T1 (de) | Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
DE60019814D1 (de) | Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten | |
ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
ATE313540T1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
ATE451123T1 (de) | Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie | |
DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |